COHANCE LIFESCIENCES [COHANCE] vs Eris Lifesciences [ERIS] Detailed Stock Comparison

COHANCE LIFESCIENCES LTD

NSE
Loading...

Eris Lifesciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: COHANCE LIFESCIENCES LTD wins in 4 metrics, Eris Lifesciences Ltd. wins in 15 metrics, with 0 ties. Eris Lifesciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric COHANCE LIFESCIENCES LTD Eris Lifesciences Ltd. Better
P/E Ratio (TTM) 72.20 44.25 Eris Lifesciences Ltd.
Price-to-Book Ratio 3.67 6.15 COHANCE LIFESCIENCES LTD
Debt-to-Equity Ratio 11.49 68.19 COHANCE LIFESCIENCES LTD
PEG Ratio -1.02 2.33 Eris Lifesciences Ltd.
EV/EBITDA 88.07 17.91 Eris Lifesciences Ltd.
Profit Margin (TTM) 5.62% 14.06% Eris Lifesciences Ltd.
Operating Margin (TTM) 8.89% 26.38% Eris Lifesciences Ltd.
EBITDA Margin (TTM) 8.89% 26.38% Eris Lifesciences Ltd.
Return on Equity 14.55% 10.75% COHANCE LIFESCIENCES LTD
Return on Assets (TTM) 8.84% 5.00% COHANCE LIFESCIENCES LTD
Free Cash Flow (TTM) $1.32B $9.10B Eris Lifesciences Ltd.
Dividend Yield N/A 0.41% N/A
1-Year Return -58.81% -11.56% Eris Lifesciences Ltd.
Price-to-Sales Ratio (TTM) 12.92 6.31 Eris Lifesciences Ltd.
Enterprise Value $140.68B $217.40B Eris Lifesciences Ltd.
EV/Revenue Ratio 13.04 7.09 Eris Lifesciences Ltd.
Gross Profit Margin (TTM) 70.82% 72.12% Eris Lifesciences Ltd.
Revenue per Share (TTM) $42 $225 Eris Lifesciences Ltd.
Earnings per Share (Diluted) $5.04 $31.54 Eris Lifesciences Ltd.
Beta (Stock Volatility) 0.16 -0.14 Eris Lifesciences Ltd.

COHANCE LIFESCIENCES LTD vs Eris Lifesciences Ltd. Stock Performance Analysis

Loading Price Chart...

COHANCE
ERIS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
COHANCE LIFESCIENCES LTD-0.96%-0.92%-9.76%42.48%-21.87%-18.85%
Eris Lifesciences Ltd.2.57%3.43%3.21%2.87%-10.51%-6.95%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
COHANCE LIFESCIENCES LTD-58.81%-59.96%-59.96%-59.96%-59.96%-59.96%
Eris Lifesciences Ltd.-11.56%119.21%94.70%132.59%132.59%132.59%

Performance & Financial Health Analysis: COHANCE LIFESCIENCES LTD vs Eris Lifesciences Ltd.

MetricCOHANCEERIS
Market Information
Market Cap i₹139.35B₹193.36B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i8,278,715174,049
90 Day Avg. Volume i3,297,180106,619
Last Close₹424.80₹1,397.10
52 Week Range₹266.70 - ₹1,121.15₹1,200.00 - ₹1,910.00
% from 52W High-62.11%-26.85%
All-Time High₹1,123.40 (May 05, 2025)₹1,910.00 (Jun 09, 2025)
% from All-Time High-62.19%-26.85%
Growth Metrics
Quarterly Revenue Growth0.77%0.11%
Quarterly Earnings Growth-0.56%0.19%
Financial Health
Profit Margin (TTM) i0.06%0.14%
Operating Margin (TTM) i0.09%0.26%
Return on Equity (TTM) i0.15%0.11%
Debt to Equity (MRQ) i11.4968.19
Cash & Liquidity
Book Value per Share (MRQ)₹99.19₹226.84
Cash per Share (MRQ)₹10.47₹5.49
Operating Cash Flow (TTM) i₹2.95B₹7.57B
Levered Free Cash Flow (TTM) i₹2.68B₹3.52B
Dividends
Last 12-Month Dividend Yield iN/A0.41%
Last 12-Month Dividend iN/A₹7.35

Valuation & Enterprise Metrics Analysis: COHANCE LIFESCIENCES LTD vs Eris Lifesciences Ltd.

MetricCOHANCE (Apr 24, 2026)ERIS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i72.2044.25
Forward P/E i34.7827.76
PEG Ratio i-1.022.33
Price to Sales (TTM) i12.926.31
Price to Book (MRQ) i3.676.15
Market Capitalization
Market Capitalization i₹139.35B₹193.36B
Enterprise Value i₹140.68B₹217.40B
Enterprise Value Metrics
Enterprise to Revenue i13.047.09
Enterprise to EBITDA i88.0717.91
Risk & Other Metrics
Beta i0.16-0.14
Book Value per Share (MRQ) i₹99.19₹226.84

Financial Statements Comparison: COHANCE LIFESCIENCES LTD vs Eris Lifesciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOHANCE (2025)ERIS (2025)
Revenue/Sales i11.72B28.79B
Cost of Goods Sold i3.07B7.30B
COGS % of Revenue i26.2%25.4%
Gross Profit i8.66B21.49B
Gross Margin i73.8%74.6%
Research & Development iN/A24.40M
Operating Income (EBIT) i3.28B7.03B
Operating Margin i28.0%24.4%
EBITDA i4.19B10.33B
EBITDA Margin i35.8%35.9%
Pre-Tax Income i3.44B4.89B
Pre-Tax Income % of Revenue i29.3%17.0%
Income Tax i791.50M1.14B
Income Tax % of Revenue i6.8%4.0%
Net Income (Profit) i2.65B3.75B
Profit Margin i22.6%13.0%

Balance Sheet & Liquidity Metrics

MetricCOHANCE (2025)ERIS (2025)
Cash & Equivalents i854.00M2.00B
Total Current Assets i8.89B12.23B
Total Current Assets % of Revenue i75.8%42.5%
Total Current Liabilities i3.65B13.81B
Total Current Liabilities % of Revenue i31.2%48.0%
Long-Term Debt i1.76B17.82B
Long-Term Debt % of Revenue i15.0%61.9%
Total Shareholders Equity i18.41B32.72B
Retained Earnings i13.84B27.93B
Retained Earnings % of Revenue i118.1%97.0%
Property, Plant & Equipment i9.95B2.36B

Cash Flow Statement Comparison

MetricCOHANCE (2025)ERIS (2025)
Operating Cash Flow i2.95B7.57B
Operating Cash Flow % of Revenue i25.2%26.3%
Capital Expenditures i-1.56B-1.55B
Free Cash Flow i1.32B9.10B
FCF Margin i11.3%31.6%
Debt Repayment i-18.50M-18.34B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCOHANCEERIS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i382.57M138.54M
Float Shares i137.91M43.42M
% Held by Insiders i63.97%68.05%
% Held by Institutions i24.58%21.83%
% Held by Public i11.45%10.12%

Dividend Analysis & Yield Comparison: COHANCE LIFESCIENCES LTD vs Eris Lifesciences Ltd.

MetricCOHANCEERIS
Last 12-Month Dividend iN/A₹7.35
Last 12-Month Dividend Yield iN/A0.41%
3-Year Avg Annual Dividend iN/A₹4.90
3-Year Avg Dividend Yield iN/A0.82%
3-Year Total Dividends iN/A₹14.70
Ex-Dividend DateN/AFeb 13, 2025